Comparative Pharmacology
Head-to-head clinical analysis: NORMOCARB HF 35 versus THAM.
Peer-Reviewed Evidence
Head-to-head clinical analysis: NORMOCARB HF 35 versus THAM.
NORMOCARB HF 35 vs THAM
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
NORMOCARB HF 35 is a fixed-dose combination of dapagliflozin (SGLT2 inhibitor) and saxagliptin (DPP-4 inhibitor). Dapagliflozin inhibits sodium-glucose cotransporter 2 in the proximal renal tubule, reducing glucose reabsorption and increasing urinary glucose excretion. Saxagliptin inhibits dipeptidyl peptidase-4, prolonging the action of incretin hormones (GLP-1 and GIP) to enhance insulin secretion and suppress glucagon release in a glucose-dependent manner.
THAM (tromethamine) is a proton acceptor that buffers hydrogen ions, treating metabolic acidosis by increasing blood pH and bicarbonate buffering capacity.
Oral: 150 mg twice daily
Intravenous administration of 300-500 mL of 0.3 M THAM solution (approximately 1-2 mEq/kg) over 30-60 minutes, repeated as needed based on blood pH and base deficit.
None Documented
None Documented
Clinical Note
moderateMechlorethamine + Digoxin
"Mechlorethamine may decrease the cardiotoxic activities of Digoxin."
Clinical Note
moderateMechlorethamine + Digitoxin
"Mechlorethamine may decrease the cardiotoxic activities of Digitoxin."
Clinical Note
moderateMechlorethamine + Deslanoside
"Mechlorethamine may decrease the cardiotoxic activities of Deslanoside."
Clinical Note
moderateMechlorethamine + Acetyldigitoxin
"Mechlorethamine may decrease the cardiotoxic activities of Acetyldigitoxin."
Terminal elimination half-life: 35 hours. In renal impairment (CrCl <30 mL/min), half-life may be prolonged to 90 hours, requiring dose adjustment.
Terminal half-life: 1-2 hours in patients with normal renal function; prolonged up to 6-8 hours in renal impairment.
Primarily renal (approx. 90% as unchanged drug), biliary/fecal <10%.
Renal: >95% excreted unchanged in urine. Biliary/fecal: negligible (<5%).
Category C
Category C
Alkalizing Agent
Alkalizing Agent